Business Description
9 Meters Biopharma was a clinical-stage company based in Raleigh, North Carolina, that worked on treatments for rare and serious digestive conditions affecting patients in North America. Its pipeline included several drug candidates targeting conditions such as short bowel syndrome, obesity, and complications from organ transplants, with its lead therapy, Vurolenatide, having reached Phase 3 clinical trials. The company also held licensing agreements with multiple partners and was co-developing Larazotide for multi-system inflammatory syndrome. In July 2023, the company sought court approval to wind down its operations through a Chapter 7 bankruptcy filing.